GET A QUOTE

Parainfluenza 1/2/3 IgM ELISA Kit

Full Name: Parainfluenza 1/2/3 IgM ELISA Kit
Reactivity: Human
Sample Type: Serum, Plasma
Sensitivity: 1.18 U/ml

BACKGROUND

Parainfluenza viruses are 15-250 nm in size, negative sense, single stranded RNA that are made up of approx. 15, 000 nucleotides. There are essentially four distinct types which are known as type 1, 2, 3 and 4. All of these have a difference in the severity of the disease but all share antigenic cross-reactivity.

In children some of the most frequent illnesses occur around the upper respiratory tract. Parainfluenza viruses are found to be very closely associated to either veterinary or human diseases. Common procedure that are used routinely to measure this virus include immunofluorescent microscopy, cell culture, PCR and ELISA. The results of the ELISA and HAI methods are comparable.

INTENDED USE

Human parainfluenza 1/2/3 IgM ELISA kit is designed for analysing in-vitro concentrations of human IgM antibodies against parainfluenza 1/2/3 (parainfluenza-1 IgM, parainfluenza-2 IgM, parainfluenza-3 IgM) with either plasma or serum. This assay has a minimum analytical sensitivity limit of 1.18 U/ml.

CONTENT

All reagents supplied need to be stored at 2 °C – 8 °C, unopened reagents will retain reactivity until expiration date. Do not use reagents beyond this date.

  • Parainfluenza antigen coated microtiter strips.
  • Negative Control (Calibrator A).
  • Positive Control (Calibrator D).
  • Cut-Off Standard (Calibrator B).
  • Weak Positive Control (Calibrator C).
  • Enzyme Conjugate.
  • TMB Substrate.
  • Sample Diluent.
  • Washing Buffer (10x).
  • Stop Solution.

SENSITIVITY

The minimum detection sensitivity level of human IgM antibodies to parainfluenza 1/2/3 (parainfluenza-1 IgM, parainfluenza-2 IgM, parainfluenza-3 IgM) using this parainfluenza-1/2/3 IgM ELISA kit was 1.18 U/ml. The dynamic range for this assay is 1.0 – 200.0 U/ml.

ASSAY CHARACTERISTICS

– Intra-Assay-Precision: 6.4 %
– Inter-Assay-Precision: 10.7 %
– Inter-Lot-Precision: 4.8 – 12.1 %
– Analytical Sensitivity: 1.22 U/mL
– Recovery: 97 – 110 %
– Linearity: 70 – 117 %
– Cross-Reactivity: No cross-reactivity to Adenovirus, Bordetella, Parainfluenza 1/2/3 and Influenza A.
– Interferences: No interferences to, hemoglobin up to 8.0 mg/mL triglycerides up to 5.0 mg/mL and bilirubin up to 0.3 mg/mL.
– Clinical Specificity: 100 %
– Clinical Sensitivity: 100 %

REFERENCES

  1. Diagnosis of parainfluenza virus infection in children and older patients by detection of specific IgM antibody. J Med Virol. (1985) 16 (2): 191-9. van der Logt J.T., et al.
  2. Enzyme immunoassays for detection of IgG and IgM antibodies to parainfluenza types 1, 2 and 3. J Virol Methods. (1989) 23 (1): 63-70. Vuorinen T. and Meurman O.
  3. The use of IgM antibody responses in the diagnosis of primary infections to measles, rubella, mumps, and M. Parainfluenzae viruses. Med Microbiol Immunol. (1978) 164 (4): 299-305. Bringuier J.P., et al.
  4. Contribution to laboratory diagnosis of mumps and parainfluenza. Acta Virol. (1988) 32 (6): 503-14. Franková V., et al.

OTHER RELATED ELISA KITS

Online Enquiry Form

"*" indicates required fields

Please check mark information required:

TESTIMONIALS arrow icon

Your secretory IgA ELISA gave good results and I was also really impressed with how quickly we received it.

L. Johnston
PhD Student / University of Glasgow

It is refreshing to know that you have a technical team that is very knowledgeable. I have already recommended your company to other researchers in our department.

Dr. P. Anderson
Lecturer / University College London (UCL)

I am a first time user and found that your instruction manual was very easy to follow. The insulin ELISA assay performed well and I was happy with the results that were generated.

J. Thomas
Senior Technician / Addenbrooke’s Hospital

I carried out a pilot study comparing the performance of many ELISA assay's from different suppliers and found your kits to be one of the better performers. We observed good linearity and tight replicates.

Dr. C. Davies
Lead Scientists / AstraZeneca

You are my first point of contact when I am looking to purchase ELISA. You have such an easy and simple system, yet it is very effective.

A. Shaw
Purchasing / University of Oxford